GRANVIA®-C Cervical Disc Prosthesis Multicenter European Pilot Study
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a prospective clinical study to assess the performance of the prosthesis according to a composite success criterion. The clinical and functional results and the patient's quality of life up to 24 months of follow-up will also be recorded.
Granvia-c is a device NOT FDA-approved and NOT under investigation in the USA.
| Condition | Intervention |
|---|---|
|
Cervicobrachial Neuralgia Cervical Discopathy |
Device: Cervical arthroplasty surgery with Granvia-C |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | The GRANVIA®-C Cervical Disc Prosthesis to Treat Symptomatic Degenerative Disc Diseases |
- Composite criterion of success [ Time Frame: 24Months ] [ Designated as safety issue: Yes ]
the success is defined by a composite criterion of 4 points. The surgery will be a success only if there is:
- A 15-point improvement in the NDI score from the preoperative baseline score
- Maintenance or improvement of the pre-op baseline neurological status
- Absence of secondary surgical intervention
- Absence of serious adverse event
- Radiologic evaluation of the motion [ Time Frame: Preop, 3M, 12M and 24M ] [ Designated as safety issue: No ]Radiologic evaluation of the motion of the operated level(s) and comparison to the motion of the adjacent levels,
- Evaluation of potential peri and post-operative adverse events related or not to prosthesis. [ Time Frame: preop, 3M, 12M, 24M ] [ Designated as safety issue: Yes ]
- Evaluation of satisfaction [ Time Frame: Preop, 3M, 12M and 24M ] [ Designated as safety issue: No ]Evaluation of satisfaction with Patient Satisfaction Index
- Evaluation of the time to return to activities (normal activity, work, sport activity) [ Time Frame: preop, 3M, 12M, 24M ] [ Designated as safety issue: No ]
- Evaluation of Pain [ Time Frame: Preop, 3M, 12M and 24M ] [ Designated as safety issue: No ]Evaluation of pain with Visual Analog Scales
- cervical alignment [ Time Frame: Preop, 3M, 12M and 24M ] [ Designated as safety issue: No ]Radiologic evaluation of the global cervical alignment
- disc height [ Time Frame: Preop, 3M, 12M and 24M ] [ Designated as safety issue: No ]Radiologic evaluation of the disc height of the operated level(s)
- Radiologic adverse events [ Time Frame: Preop, 3M, 12M and 24M ] [ Designated as safety issue: No ]Radiologic evaluation of adverse events such as migration, subsidence
| Estimated Enrollment: | 100 |
| Study Start Date: | August 2012 |
| Estimated Study Completion Date: | August 2017 |
| Estimated Primary Completion Date: | August 2015 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
Radiculopathy Cervical
Radiculopathy, Cervical
|
Device: Cervical arthroplasty surgery with Granvia-C
Discectomy and Cervical arthroplasty according to standard practice of the surgeon
|
Detailed Description:
Anterior cervical arthrodesis has been widely used to treat the degenerative cervical spine. Although the results of ACDF are generally in the good to excellent range, interbody fusion of the cervical spine after cervical discectomy, aside from causing restriction of neck movements, also accelerates degeneration of adjacent disc levels because of the increased stress from fusion. Long-term radiographic follow-up of patients with anterior cervical fusion has demonstrated degenerative changes in the non-fused segments of the spine including disc space narrowing and osteophyte formation.
To conclude, fusion provokes a functional overload of the discs bordering the fusion that is directly correlated to the number of fused levels. Radiographic observations show a greater mechanical stress on the discs, especially in the arthrodeses involving more than one level.
Artificial discs were designed to replace the entire intervertebral disc and to preserve the physiological motion of the operated level. Several prostheses with different concepts were commercialized. Published clinical studies reported a preserved motion and improved clinical results (Neck Disability Index, Pain Visual Analogic Scale, Quality of Life).
The cervical disc prosthesis GRANVIA®-C was designed to replace the intervertebral discs of the cervical spine, to restore the disc height and to restore segmental motion.
A prospective clinical study has been set up to evaluate the performance of the prosthesis
Granvia-c is a device NOT FDA-approved and NOT under investigation in the USA.
Eligibility| Ages Eligible for Study: | 21 Years to 55 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
People with Cervicobrachial neuralgia due to symptomatic cervical discopathy
Inclusion Criteria:
- Cervicobrachial neuralgia due to symptomatic cervical discopathy
Presence of pain (arm or arm and neck) and/or a neurologic deficit with a radiographic confirmation (by CT, MRI, X-ray, etc.) of any of the following:
- Herniated nucleus pulposus
- Spondylosis (defined by the presence of osteophytes)
- Degenerative Disc Disease at a single level or 2-level(s) adjacent or not between C3 and C7
Exclusion Criteria (non exhaustive):
- Asymptomatic degenerative disc disease (DDD)
- DDD of 3-levels or more
- Axial neck pain as the solitary symptom
- Severe spondylosis at the level to be treated by arthroplasty as
Characterized by any of the following:
- Bridging osteophytes
- A loss of disc height greater than 50% (compared to adjacent levels)
- Absence of motion (<2°)
- Any prior spine surgery at any cervical level, especially fusion procedure; views) for the level operated by arthroplasty
- Tumor
- Deformity or fracture of the cervical vertebrae
Active systemic infection or infection at the operative site(s)
- Pregnant or interested in becoming pregnant in the next three years;
- Advanced emphysema, Alzheimer's disease or other medical conditions that would interfere with patient self-assessment of function, pain or quality of life
Contacts and Locations| Belgium | |
| CHR Namur | Recruiting |
| Namur, Belgium, 5000 | |
| Contact: Milbouw, MD germain.milbouw@chr-namur.be | |
| Principal Investigator: Milbouw, MD | |
| France | |
| Tripode Hospital | Recruiting |
| Bordeaux, France, 33000 | |
| Contact: Guérin, MD pguerin_patrick@yahoo.fr | |
| Principal Investigator: Guérin, MD | |
| Clairval hospital | Recruiting |
| Marseille, France, 13009 | |
| Contact: Barat, MD jlbarat1@yahoo.fr | |
| Principal Investigator: Barat, MD | |
| Principal Investigator: | John Yeh, MD | Royal London Hospital, UK |
| Principal Investigator: | Frédéric Schils, MD | CHC Liège, Belgium |
| Principal Investigator: | Hans Meisel, MD | Halle Klinike, Germany |
| Principal Investigator: | Patrick Guérin, MD | CHU Bordeaux, France |
More Information
No publications provided
| Responsible Party: | Medicrea International |
| ClinicalTrials.gov Identifier: | NCT01518582 History of Changes |
| Other Study ID Numbers: | #0802 |
| Study First Received: | January 5, 2012 |
| Last Updated: | September 11, 2012 |
| Health Authority: | France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis) France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé France: Committee for the Protection of Personnes France: Conseil National de l'Ordre des Médecins |
Keywords provided by Medicrea International:
|
Cervicobrachial neuralgia symptomatic cervical discopathy |
Additional relevant MeSH terms:
|
Brachial Plexus Neuritis Brachial Plexus Neuropathies Neuralgia Intervertebral Disk Degeneration Intervertebral Disk Displacement Peripheral Nervous System Diseases Neuromuscular Diseases Nervous System Diseases Neuritis |
Pain Neurologic Manifestations Signs and Symptoms Spinal Diseases Bone Diseases Musculoskeletal Diseases Hernia Pathological Conditions, Anatomical |
ClinicalTrials.gov processed this record on June 18, 2013